X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18797) 18797
Book Chapter (17) 17
Dissertation (16) 16
Magazine Article (16) 16
Newsletter (12) 12
Conference Proceeding (4) 4
Government Document (4) 4
Newspaper Article (4) 4
Publication (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14995) 14995
female (10921) 10921
middle aged (8029) 8029
male (7905) 7905
doxorubicin (7545) 7545
oncology (7464) 7464
doxorubicin - administration & dosage (6995) 6995
adult (6919) 6919
aged (6579) 6579
doxorubicin - adverse effects (6479) 6479
chemotherapy (6196) 6196
antineoplastic combined chemotherapy protocols - therapeutic use (6131) 6131
antineoplastic combined chemotherapy protocols - adverse effects (5226) 5226
cancer (4628) 4628
animals (3362) 3362
treatment outcome (3229) 3229
cyclophosphamide - administration & dosage (3105) 3105
doxorubicin - therapeutic use (2840) 2840
breast neoplasms - drug therapy (2676) 2676
anthracyclines (2394) 2394
vincristine - administration & dosage (2201) 2201
therapy (2186) 2186
antineoplastic combined chemotherapy protocols - administration & dosage (2140) 2140
pharmacology & pharmacy (2022) 2022
antineoplastic agents - adverse effects (1961) 1961
adolescent (1930) 1930
cyclophosphamide - adverse effects (1926) 1926
breast cancer (1823) 1823
drug administration schedule (1776) 1776
hematology (1733) 1733
cyclophosphamide (1710) 1710
care and treatment (1673) 1673
cisplatin - administration & dosage (1658) 1658
aged, 80 and over (1554) 1554
prognosis (1516) 1516
toxicity (1495) 1495
disease-free survival (1487) 1487
neoplasm staging (1484) 1484
antibiotics, antineoplastic - adverse effects (1473) 1473
combined modality therapy (1465) 1465
mice (1446) 1446
cardiotoxicity (1433) 1433
vincristine - adverse effects (1396) 1396
antineoplastic agents - therapeutic use (1376) 1376
retrospective studies (1366) 1366
cisplatin (1348) 1348
survival rate (1327) 1327
medicine & public health (1314) 1314
prednisone - administration & dosage (1307) 1307
survival analysis (1273) 1273
antineoplastic agents - administration & dosage (1260) 1260
dose-response relationship, drug (1241) 1241
paclitaxel (1229) 1229
neoplasms - drug therapy (1211) 1211
tumors (1203) 1203
trial (1182) 1182
follow-up studies (1179) 1179
apoptosis (1165) 1165
survival (1159) 1159
research (1150) 1150
breast neoplasms - pathology (1138) 1138
time factors (1125) 1125
child (1111) 1111
analysis (1105) 1105
doxorubicin - pharmacology (1057) 1057
fluorouracil - administration & dosage (1048) 1048
prospective studies (1037) 1037
rats (1032) 1032
drug therapy (1030) 1030
risk factors (1030) 1030
cyclophosphamide - therapeutic use (990) 990
adriamycin (971) 971
doxorubicin - analogs & derivatives (967) 967
health aspects (963) 963
methotrexate - administration & dosage (960) 960
antibiotics, antineoplastic - administration & dosage (956) 956
cancer therapies (955) 955
etoposide - administration & dosage (948) 948
nanoparticles (946) 946
drug delivery systems (941) 941
carcinoma (917) 917
prednisone - adverse effects (910) 910
cisplatin - adverse effects (908) 908
drugs (900) 900
pegylated liposomal doxorubicin (898) 898
cell line, tumor (892) 892
drug therapy, combination (890) 890
remission induction (863) 863
combination (845) 845
vincristine - therapeutic use (813) 813
heart - drug effects (809) 809
ovarian neoplasms - drug therapy (804) 804
paclitaxel - administration & dosage (782) 782
chemotherapy, adjuvant (762) 762
lymphomas (762) 762
bleomycin - administration & dosage (757) 757
neoplasm metastasis (755) 755
lung neoplasms - drug therapy (746) 746
young adult (745) 745
clinical trials (731) 731
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17985) 17985
Japanese (441) 441
German (204) 204
French (131) 131
Chinese (120) 120
Russian (91) 91
Spanish (84) 84
Italian (65) 65
Polish (43) 43
Portuguese (30) 30
Czech (17) 17
Hungarian (15) 15
Dutch (8) 8
Korean (8) 8
Norwegian (6) 6
Ukrainian (5) 5
Danish (4) 4
Hebrew (4) 4
Serbian (3) 3
Bulgarian (2) 2
Persian (2) 2
Slovak (2) 2
Lithuanian (1) 1
Romanian (1) 1
Slovenian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | Radiotherapy Dosage | no | Doxorubicin/adverse effects | Etoposide/adverse effects | Procarbazine/adverse effects | Prospective Studies | Hodgkin Disease/drug therapy | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Positron-Emission Tomography | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Prednisone/adverse effects | Treatment Failure | Adolescent | Survival Analysis | Adult | Female | Cyclophosphamide/adverse effects | Vincristine/adverse effects | Neoplasm Staging | Bleomycin/adverse effects | SURVIVAL | ABVD | MEDICINE, GENERAL & INTERNAL | COMBINATIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | PROGNOSTIC SCORE | RISK | STANFORD-V | PROGRESSION | MOPP/ABV HYBRID | Doxorubicin - therapeutic use | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - therapeutic use | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2008, Volume 58, Issue 4, pp. 545 - 570
Chemotherapeutic agents give rise to numerous well described adverse effects that may affect the skin, hair, mucous membranes, or nails... 
Dermatology | CELL LUNG-CANCER | CHRONIC MYELOGENOUS LEUKEMIA | GROWTH-FACTOR RECEPTOR | PEGYLATED LIPOSOMAL DOXORUBICIN | PHASE-II TRIAL | RADIATION-RECALL DERMATITIS | CHRONIC LYMPHOCYTIC-LEUKEMIA | TYROSINE-KINASE INHIBITOR | CHRONIC MYELOID-LEUKEMIA | HAND-FOOT SYNDROME | DERMATOLOGY | Erlotinib Hydrochloride | Niacinamide - analogs & derivatives | Drug Eruptions - pathology | Humans | Antibodies, Monoclonal - adverse effects | Phenylurea Compounds | Protein Kinase Inhibitors - adverse effects | Benzenesulfonates - adverse effects | Antibodies, Monoclonal, Humanized | Pyridines - adverse effects | Fusion Proteins, bcr-abl | Antineoplastic Agents - adverse effects | Nail Diseases - chemically induced | Drug-Related Side Effects and Adverse Reactions | Hair Diseases - chemically induced | Pyrroles - adverse effects | Mucous Membrane - drug effects | Cetuximab | Taxoids - adverse effects | Platinum Compounds - adverse effects | Drug Eruptions - etiology | Skin Diseases - chemically induced | Imatinib Mesylate | Piperazines - adverse effects | Antimetabolites - adverse effects | Indoles - adverse effects | Signal Transduction - drug effects | Pyrimidines - adverse effects | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Benzamides | Proteasome Inhibitors | Skin - drug effects | Protein-Tyrosine Kinases - antagonists & inhibitors | Chemotherapy | Platelet-derived growth factor | Formulae, receipts, prescriptions | Dermatologic agents | Lung cancer, Non-small cell | Cancer | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 9999, pp. 1156 - 1164
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 5, pp. 592 - 598
Purpose To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive... 
2ND CANCER-RISK | RANDOMIZED-TRIALS | ONCOLOGY | DNA TOPOISOMERASE-II | ALKYLATING-AGENTS | COMBINED-MODALITY TREATMENT | DISEASE | MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROMES | CHEMOTHERAPY | ACUTE PROMYELOCYTIC LEUKEMIA | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Humans | Leukemia, Myeloid, Acute - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Mechlorethamine - adverse effects | Male | Risk | Leukemia, Myeloid, Acute - etiology | Incidence | Hodgkin Disease - radiotherapy | Melphalan - adverse effects | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Retrospective Studies | Databases, Factual | Radiotherapy Dosage | Prednisone - adverse effects | Drug Administration Schedule | California - epidemiology | Clinical Trials as Topic | Bleomycin - adverse effects | Academic Medical Centers | Myelodysplastic Syndromes - epidemiology | Myelodysplastic Syndromes - etiology | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Methotrexate - adverse effects | Procarbazine - adverse effects | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Hema14 | Hema13 | Hema12 | ORIGINAL REPORTS
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 3, pp. 203 - 212
.... BEACOPP therapy was associated with higher initial rates of complete response and freedom from relapse but also with more short-term and long-term toxic effects... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Chest, ISSN 0012-3692, 02/2008, Volume 133, Issue 2, pp. 528 - 538
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
INHIBIN-B | PRESERVATION | OUTCOME MEASURE | OVARIAN RESERVE | ONCOLOGY | TERM FOLLOW-UP | DISEASE | FEMALE CANCER SURVIVORS | ANTI-MULLERIAN HORMONE | CHEMOTHERAPY | SERUM MARKER | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article